Quality control for tumour markers

Edited by the Laboratorytalk editorial team Sep 12, 2005

Randox's new and improved Tumour Marker Control features two new analytes, CA72-4 and thyroglobulin, and has received FDA clearance

The control now features eighteen tumour markers.

The tri-level control is liquid stable and has an open-vial stability of thirty days.

The pack size is still 9x2ml.

Randox assayed quality controls are supplied with target values and ranges for a wide range of instrumentation and methodologies.

Tel +44 28 9442 2413

Randox develops adhesion molecules array
Randox Laboratories has developed a biochip array for the simultaneous quantitative testing of five cell adhesion molecules (CAMs).
RanplexCRC able to detect bowel cancer
RanplexCRC from Randox is a diagnostic test that can detect 28 polymorphisms associated with colorectal cancer in a single stool sample.
Biochip measures 12 analytes simultaneously
Evidence, the revolutionary new biochip system now available, measures 12 analytes simultaneously in human samples, with a sample throughput of 1296
Improve analytical quality with global EQA scheme
Riqas, ISO 13485 and Ukas accredited, is the largest global EQA scheme, designed to maintain and improve the quality of clinical testing
Evidence Investigator helps maximise throughput
The Evidence Investigator from Randox is a bench top semi-automated analyser that utilises biochip array technology for multi-analyte testing

Laboratorytalk